Loxiglumide (CR1505) inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins.
Molecular Weight
461.38
Molecular Formula
C21H30Cl2N2O5
Form
Lyophilized powder
Purity
>98%
Applications
Loxiglumide (CR1505) can be used to research and develop therapeutic strategies for certain diseases that involve excessive activation of GPCR-G protein signaling pathways.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
